Diagnostic value of dual-tracer PET/CT with [18F]FDG and PSMA ligands in prostate cancer: an updated systematic review

Diagnostic value of dual-tracer PET/CT with [18F]FDG and PSMA ligands in prostate cancer: an updated systematic review

BackgroundProstate-specific membrane antigen (PSMA) ligand PET/CT has significantly improved prostate cancer (PCa) imaging. However, in patients with poorly differentiated PCa or neuroendocrine transdifferentiation, [18F]fluorodeoxyglucose ([18F]FDG) PET/CT may provide additional diagnostic informat...

Full description

Saved in:

Bibliographic Details
Main Authors:	Cesare Michele Iacovitti, Marco Cuzzocrea, Alessio Rizzo, Matteo Bauckneht, Roberto C. Delgado Bolton, Gaetano Paone, Giorgio Treglia
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Medicine
Subjects:	prostate cancer PSMA [18F]FDG PET/CT dual-tracer hybrid imaging
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2025.1607227/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Prevalence and Significance of Incidental Positron Emission Tomography Findings in the Brain Using Radiotracers Other than [<sup>18</sup>F]FDG: A Systematic Review and Meta-Analysis
by: Cesare Michele Iacovitti, et al.
Published: (2025-05-01)

Meta-Analysis on the Prevalence and Significance of Incidental Findings in the Thyroid Gland Using Other PET Radiopharmaceuticals Beyond [<sup>18</sup>F]FDG
by: Cesare Michele Iacovitti, et al.
Published: (2025-05-01)

“Rosary Sign” at Somatostatin Receptor PET in a Case of Recurrent Meningioma
by: Cesare Michele Iacovitti, et al.
Published: (2024-11-01)

DUAL-TRACER PET/CT IMAGING IN HEPATOCELLULAR CARCINOMA: COMPARING THE PERFORMANCE OF 18F-FDG AND 18F-PSMA
by: Giulia Picciola Bordoni, et al.
Published: (2025-05-01)

FDG PET/CT AND PSMA PET/CT IN MUSCULOSKELETAL SOFT TISSUE SARCOMAS
by: Ellen Nogueira Lima, et al.
Published: (2025-05-01)

CT-SEGMENTED BONE SUV IN MULTIPLE MYELOMA: A COMPARATIVE STUDY OF ¹⁸F-FDG AND ⁶⁸GA-PSMA PET/CT
by: Alexandre Mercuri Barbosa, et al.
Published: (2025-05-01)

Towards Dual-Tracer SPECT for Prostate Cancer Imaging Using [<sup>99m</sup>Tc]Tc-PSMA-I&S and [<sup>111</sup>In]In-RM2
by: Carolina Giammei, et al.
Published: (2025-07-01)

Comparison of 18F-FDG and 68-PSMA-11 in PET for prostate cancer diagnosis
by: Natalia Fulle, et al.
Published: (2022-12-01)

COMPARISON BETWEEN 18F-PSMA AND 18F-FDG RADIOTRACERS FOR PET/CT IN THE EVALUATION OF PATIENTS WITH METASTATIC MELANOMA
by: Thiago Soare Rocha Alves, et al.
Published: (2025-05-01)

Head-to-head comparison of 68Ga-PSMA-11 and 18F-FDG in delayed PET/CT imaging in prostate cancer diagnosis
by: Biyao Hu, et al.
Published: (2025-04-01)

A prospective, multi-centre trial of PSMA-PET compared to FDG-PET for staging of newly diagnosed high risk prostate cancer
by: Matthew J. Roberts, et al.
Published: (2025-07-01)

THE ROLE OF PSMA PET/CT IN THE CHARACTERIZATION OF HEAD AND NECK SQUAMOUS CELL CARCINOMA
by: Hadila da Silva Veras Sousa, et al.
Published: (2025-05-01)

EVALUATION OF 18F-PSMA PET/CT UPTAKE IN PATIENTS WITH GASTRIC ADENOCARCINOMA: AN EXPLORATORY ANALYSIS
by: Renata Erbert Contriciani, et al.
Published: (2025-05-01)

PSMA PET/CT in the low- to intermediate-risk prostate cancer: when and why?
by: Luca Sofia, et al.
Published: (2024-10-01)

Different PSMA Radiopharmaceuticals: A Comparative Study of [<sup>18</sup>F]F-PSMA-1007, [<sup>18</sup>F]F-JK-PSMA-7, and [<sup>99m</sup>Tc]Tc-PSMA-I&S in the Skeletal System
by: Zsófia Sára Mikó, et al.
Published: (2024-10-01)

Intra-Individual Comparisons of [18F]fluorodeoxyglucose and Prostate-Specific Membrane Antigen Positron Emission Tomography in Prostate Cancer Patients Across Different Disease States: New Insights into Disease Heterogeneity
by: Stephen McGeorge, et al.
Published: (2024-12-01)

Hybrid tracer - A modified novel extra oral tracer
by: Nithin Kumar sonnahalli, et al.
Published: (2022-11-01)

[18F]Tetrafluoroborate, a new NIS PET/CT radiopharmaceutical: an overview focused on differentiated thyroid cancer
by: Arnoldo Piccardo, et al.
Published: (2025-02-01)

PSMA PET/CT scan reveals incidental meningioma in a prostate cancer patient
by: Venetia A. Florou, et al.
Published: (2025-05-01)

PSMA5 as a modulator of glioblastoma senescence and prognosis
by: Jiahao Yao, et al.
Published: (2025-07-01)

Synthetic DNA Fragments as High‐Resolution Tracers for Hydrological Parameter Inversion
by: Xinlin Li, et al.
Published: (2025-07-01)

Tracer Velocity Versus Bedload Velocity: Derivation of the Unsteady Virtual Bedload Velocity From Decelerating Tracers
by: M. Klösch, et al.
Published: (2024-08-01)

A Review of Green's Function Methods for Tracer Timescales and Pathways in Ocean Models
by: Thomas W. N. Haine, et al.
Published: (2025-07-01)

Juvenile Idiopathic Arthritis Subtype- and Sex-specific Associations with Genetic Variants in the PSMA6/PSMC6/PSMA3 Gene Cluster
by: Tatjana Sjakste, et al.
Published: (2014-10-01)

Comparing the Diagnostic Performance of [18F]PSMA‐1007 With [68Ga]Ga‐PSMA‐11 in PET/CT Imaging and Staging of Recurrent Prostate Cancer
by: Negar Abdi, et al.
Published: (2025-03-01)

Biphasic contrast-enhanced [18F]PSMA-1007 PET/CT imaging to improve the detection of local relapse of prostate cancer
by: Eduards Mamlins, et al.
Published: (2025-05-01)

Emerging PET-radiotracers in cardiovascular, neuro-inflammation, lung and rheumatological diseases: a narrative review
by: Domenico Albano, et al.
Published: (2025-08-01)

Preclinical and clinical evaluation of [64Cu]Cu-PSMA-Q PET/CT for prostate cancer detection and its comparison with [18F]FDG imaging
by: Fei Chen, et al.
Published: (2025-04-01)

Preliminary clinical study of p-iodo benzoyl moiety-modified PSMA inhibitors and prospective comparison with 68Ga-PSMA-11
by: Jianpeng Cao, et al.
Published: (2025-06-01)

PSMA response evaluation in follow-up PSMA-PET/CT after stereotactic ablative body radiotherapy (SABR) for oligometastases in prostate cancer
by: Anna-Lena Zang, et al.
Published: (2025-09-01)

The tumour sink effect on 68Ga-PSMA-PET/CT in metastatic castration-resistant prostate cancer and its implications for PSMA-RPT: a sub-analysis of the 3TMPO study
by: Atefeh Zamanian, et al.
Published: (2025-07-01)

Solution of the inverse problem of tracer tests interpretation results for oil reservoirs in the presence of low resistance channels
by: Konstantin M. Fedorov, et al.
Published: (2024-07-01)

Real world experience with [99mTc]Tc-HYNIC-iPSMA SPECT prostate cancer detection: interim results from the global NOBLE registry
by: Pete Tually, et al.
Published: (2024-12-01)

Sistem Informasi Tracer Study Alumni Universitas Negeri Semarang Dengan Aplikasi Digital Maps
by: Zulfikar Adi Nugroho, et al.
Published: (2014-10-01)

Revising Common Approaches for Calibration: Insights From a 1‐D Tracer‐Aided Hydrological Model With High‐Dimensional Parameters and Objectives
by: Songjun Wu, et al.
Published: (2025-01-01)

Which PSMA PET/CT interpretation criteria most effectively diagnose prostate cancer? a retrospective cohort study
by: Le Ma, et al.
Published: (2025-01-01)

Improvement of End-of-Synthesis Radiochemical Purity of <sup>177</sup>Lu-DOTA-PSMA-Ligands with Alternative Synthesis Approaches: Conversion Upswing and Side-Products Minimization
by: Anton Larenkov, et al.
Published: (2024-11-01)

Can Biogeochemical Tracer Observations Constrain Southern Ocean Diapycnal Mixing Rates?
by: Elizabeth Ellison, et al.
Published: (2025-04-01)

Statistical Analysis of the Results of Test Artillery Tracers
by: Dariusz AMPUŁA
Published: (2020-12-01)

Evaluation the Electronic Properties of Glu-Ureido Template via Ab-Initio Study as Target Specific for PSMA
by: Mohd. Faheem, et al.
Published: (2024-11-01)